The global gene synthesis (research use) market size is expected to reach USD 5.14 billion by 2030 and is expected to grow at a CAGR of 16.1% from 2023 to 2030. The market growth is primarily propelled by the growing number of research & development activities, increasing market competition, and the rising development in the field of synthetic biology. The wide range of applications associated with gene synthesis is also projected to drive the market growth. The methods involved in gene synthesis have unique advantages and make it feasible for widespread use. For instance, the solid-phase synthesis technique involved in gene synthesis allows for the acceleration of synthesis reaction by using solution-phase reagents in excess. ![Global Gene Synthesis (Research Use) Market]( "Global Gene Synthesis (Research Use) Market")
It can be conducted without the need for a purification process after each step. In addition, this method helps in improving the efficiency of the synthesis process. Thus, several companies, including Agilent Technology and Blue Heron Biotech, use solid-phase synthesis methods for gene synthesis. The market growth has been fueled significantly during the last few years owing to the growing interest in synthetic biology and gene synthesis research and development activities. In addition, established research institutions and universities that conduct research activities on synthetic biology and gene synthesis are expected to support the market growth. For instance, the Center for Synthetic Biology at the University of Copenhagen is one of the leading departments conducting research on synthetic biology in Denmark.
In addition, Integrated DNA Technologies (IDT), a major company in the gene synthesis market, introduced the Collab Network in February 2023, which unites industry partners and researchers for impactful research and technological development. These factors are expected to augment the growth in gene synthesis in the coming years. Furthermore, the growing industry competition strengthens gene synthesis services. Key companies implement various approaches to provide cost-effective services and bolster their position in the industry. These market players are focusing on upcoming opportunities in the market. For instance, a team of Evonetix, a company in gene synthesis, attended the Synthetic Biology: Engineering, Evolution & Design (SEED) 2023 conference in Los Angeles to understand the advances in synthetic biology, which can help them reinforce their position in the gene synthesis and synthetic biology industry.
It can be conducted without the need for a purification process after each step. In addition, this method helps in improving the efficiency of the synthesis process. Thus, several companies, including Agilent Technology and Blue Heron Biotech, use solid-phase synthesis methods for gene synthesis. The market growth has been fueled significantly during the last few years owing to the growing interest in synthetic biology and gene synthesis research and development activities. In addition, established research institutions and universities that conduct research activities on synthetic biology and gene synthesis are expected to support the market growth. For instance, the Center for Synthetic Biology at the University of Copenhagen is one of the leading departments conducting research on synthetic biology in Denmark.
In addition, Integrated DNA Technologies (IDT), a major company in the gene synthesis market, introduced the Collab Network in February 2023, which unites industry partners and researchers for impactful research and technological development. These factors are expected to augment the growth in gene synthesis in the coming years. Furthermore, the growing industry competition strengthens gene synthesis services. Key companies implement various approaches to provide cost-effective services and bolster their position in the industry. These market players are focusing on upcoming opportunities in the market. For instance, a team of Evonetix, a company in gene synthesis, attended the Synthetic Biology: Engineering, Evolution & Design (SEED) 2023 conference in Los Angeles to understand the advances in synthetic biology, which can help them reinforce their position in the gene synthesis and synthetic biology industry.
Gene Synthesis (Research Use) Market Report Highlights
- The solid-phase synthesis segment witnessed the highest revenue share in 2022 due to various benefits & advantages offered by this method and its high adoption by many players
- The antibody DNA synthesis services segment held the largest revenue share in 2022 due to the high adoption of gene synthesis and its effectiveness in developing antibodies
- The gene & cell therapy development application segment held the largest revenue share in 2022 and is expected to register the fastest CAGR over the forecast period. A rising number of gene & cell therapy development activities drives segment growth
- The clinical research phase segment held the largest revenue share in 2022 and is expected to witness the fastest CAGR over the forecast period. Supportive government policies and the important role of gene synthesis in developing gene therapies are anticipated to drive the segment growth
- The academic & government research institutions end-use segment accounted for the largest share in 2022. The growing interest and emphasis on synthetic biology research are expected to propel the segment's growth
- North America held the largest market share in 2022 due to the presence of various prominent players in the region. Asia Pacific is anticipated to register the fastest CAGR during the forecast period owing to the rising number of research activities for the development of therapeutics
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Market definitions
1.2. Information Procurement
1.2.1. Market formulation & data visualization
1.2.2. Data validation & publishing
1.3. Research Assumptions
1.4. Research Methodology
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.1.1. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. Global Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Obective 2
1.1.1. Market definitions
1.2. Information Procurement
1.2.1. Market formulation & data visualization
1.2.2. Data validation & publishing
1.3. Research Assumptions
1.4. Research Methodology
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.1.1. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. Global Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Obective 2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Rising investment in synthetic biology market
3.3.1.2. Advent of enzymatic DNA synthesis process
3.3.1.3. Technological advancements in the DNA synthesis platforms
3.3.1.4. Declining price of DNA synthesis & sequencing
3.3.2. Market Restraint Analysis
3.3.2.1. Lack of skilled professionals
3.3.2.2. Misuse of gene synthesis
3.4. Industry Analysis Tools
3.4.1. Porter’s Five Forces Analysis
3.4.2. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.4.3. COVID-19 Impact Analysis
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Rising investment in synthetic biology market
3.3.1.2. Advent of enzymatic DNA synthesis process
3.3.1.3. Technological advancements in the DNA synthesis platforms
3.3.1.4. Declining price of DNA synthesis & sequencing
3.3.2. Market Restraint Analysis
3.3.2.1. Lack of skilled professionals
3.3.2.2. Misuse of gene synthesis
3.4. Industry Analysis Tools
3.4.1. Porter’s Five Forces Analysis
3.4.2. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.4.3. COVID-19 Impact Analysis
Chapter 4. Gene Synthesis (Research Use) Market: Method Estimates & Trend Analysis
4.1. Global Gene Synthesis (Research Use) Market: Method Movement Analysis
4.2. Solid-phase Synthesis
4.2.1. Solid Phase Synthesis Market, 2018 - 2030 (USD Million)
4.3. Chip-based Synthesis
4.3.1. Chip Based Synthesis Market, 2018 - 2030 (USD Million)
4.4. PCR-based Enzyme Synthesis
4.4.1. PCR based Enzyme Synthesis Market, 2018 - 2030 (USD Million)
4.2. Solid-phase Synthesis
4.2.1. Solid Phase Synthesis Market, 2018 - 2030 (USD Million)
4.3. Chip-based Synthesis
4.3.1. Chip Based Synthesis Market, 2018 - 2030 (USD Million)
4.4. PCR-based Enzyme Synthesis
4.4.1. PCR based Enzyme Synthesis Market, 2018 - 2030 (USD Million)
Chapter 5. Gene Synthesis (Research Use) Market: Service Estimates & Trend Analysis
5.1. Global Gene Synthesis (Research Use) Market: Services Movement Analysis
5.2. Antibody DNA Synthesis
5.2.1. Antibody DNA Synthesis Market, 2018 - 2030 (USD Million)
5.3. Viral DNA Synthesis
5.3.1. Viral DNA Synthesis Market, 2018 - 2030 (USD Million)
5.4. Others
5.4.1. Others Market, 2018 - 2030 (USD Million)
5.2. Antibody DNA Synthesis
5.2.1. Antibody DNA Synthesis Market, 2018 - 2030 (USD Million)
5.3. Viral DNA Synthesis
5.3.1. Viral DNA Synthesis Market, 2018 - 2030 (USD Million)
5.4. Others
5.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Gene Synthesis (Research Use) Market: Application Estimates & Trend Analysis
6.1. Global Gene Synthesis (Research Use) Market: Application Movement Analysis
6.2. Gene & Cell Therapy Development
6.2.1. Gene & Cell Therapy Development Market, 2018 - 2030 (USD Million)
6.3. Vaccine Development
6.3.1. Vaccine Development Market, 2018 - 2030 (USD Million)
6.4. Others
6.4.1. Others Market, 2018 - 2030 (USD Million)
6.2. Gene & Cell Therapy Development
6.2.1. Gene & Cell Therapy Development Market, 2018 - 2030 (USD Million)
6.3. Vaccine Development
6.3.1. Vaccine Development Market, 2018 - 2030 (USD Million)
6.4. Others
6.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Gene Synthesis (Research Use) Market: Research Phase Estimates & Trend Analysis
7.1. Global Gene Synthesis (Research Use) Market: Research Phase Movement Analysis
7.2. Preclinical
7.2.1. Preclinical Market, 2018 - 2030 (USD Million)
7.3. Clinical
7.3.1. Clinical Market, 2018 - 2030 (USD Million)
7.2. Preclinical
7.2.1. Preclinical Market, 2018 - 2030 (USD Million)
7.3. Clinical
7.3.1. Clinical Market, 2018 - 2030 (USD Million)
Chapter 8. Gene Synthesis (Research Use) Market: End-use Estimates & Trend Analysis
8.1. Global Gene Synthesis (Research Use) Market: End-use Movement Analysis
8.2. Biopharmaceutical & Pharmaceutical Companies
8.2.1. Biopharmaceutical & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
8.3. Academic & Government Research Institutes
8.3.1. Academic & Government Research Institutes Market, 2018 - 2030 (USD Million)
8.4. Contract Research Organizations
8.4.1. Contract Research Organizations Market, 2018 - 2030 (USD Million)
8.2. Biopharmaceutical & Pharmaceutical Companies
8.2.1. Biopharmaceutical & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
8.3. Academic & Government Research Institutes
8.3.1. Academic & Government Research Institutes Market, 2018 - 2030 (USD Million)
8.4. Contract Research Organizations
8.4.1. Contract Research Organizations Market, 2018 - 2030 (USD Million)
Chapter 9. Gene Synthesis (Research Use) Market: Region Estimates & Trend Analysis
9.1. Gene Synthesis (Research Use) Market: Region Outlook
9.2. North America
9.2.1. North America gene synthesis (research use) market estimates and forecast, 2018 - 2030 (USD Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Target Disease Prevalence
9.2.2.3. Competitive Scenario
9.2.2.4. Regulatory Framework
9.2.2.5. U.S. gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Target Disease Prevalence
9.2.3.3. Competitive Scenario
9.2.3.4. Regulatory Framework
9.2.3.5. Canada gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3. Europe
9.3.1. Europe gene synthesis (research use) market estimates and forecast, 2018 - 2030 (USD Million)
9.3.2. Germany
9.3.2.1. Key Country Dynamics
9.3.2.2. Target Disease Prevalence
9.3.2.3. Competitive Scenario
9.3.2.4. Regulatory Framework
9.3.2.5. Germany gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.3. France
9.3.3.1. Key Country Dynamics
9.3.3.2. Target Disease Prevalence
9.3.3.3. Competitive Scenario
9.3.3.4. Regulatory Framework
9.3.3.5. France gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.4. UK
9.3.4.1. Key Country Dynamics
9.3.4.2. Target Disease Prevalence
9.3.4.3. Competitive Scenario
9.3.4.4. Regulatory Framework
9.3.4.5. UK gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Target Disease Prevalence
9.3.5.3. Competitive Scenario
9.3.5.4. Regulatory Framework
9.3.5.5. Italy gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Target Disease Prevalence
9.3.6.3. Competitive Scenario
9.3.6.4. Regulatory Framework
9.3.6.5. Spain gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.7. Denmark
9.3.7.1. Key Country Dynamics
9.3.7.2. Target Disease Prevalence
9.3.7.3. Competitive Scenario
9.3.7.4. Regulatory Framework
9.3.7.5. Denmark gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.8. Sweden
9.3.8.1. Key Country Dynamics
9.3.8.2. Target Disease Prevalence
9.3.8.3. Competitive Scenario
9.3.8.4. Regulatory Framework
9.3.8.5. Sweden gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Target Disease Prevalence
9.3.9.3. Competitive Scenario
9.3.9.4. Regulatory Framework
9.3.9.5. Norway gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.10. The Netherlands
9.3.10.1. Key Country Dynamics
9.3.10.2. Target Disease Prevalence
9.3.10.3. Competitive Scenario
9.3.10.4. Regulatory Framework
9.3.10.5. The Netherlands gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.11. Switzerland
9.3.11.1. Key Country Dynamics
9.3.11.2. Target Disease Prevalence
9.3.11.3. Competitive Scenario
9.3.11.4. Regulatory Framework
9.3.11.5. Switzerland gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific gene synthesis (research use) market estimates and forecast, 2018 - 2030 (USD Million)
9.4.2. Japan
9.4.2.1. Key Country Dynamics
9.4.2.2. Target Disease Prevalence
9.4.2.3. Competitive Scenario
9.4.2.4. Regulatory Framework
9.4.2.5. Japan gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.4.3. China
9.4.3.1. Key Country Dynamics
9.4.3.2. Target Disease Prevalence
9.4.3.3. Competitive Scenario
9.4.3.4. Regulatory Framework
9.4.3.5. China gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Target Disease Prevalence
9.4.4.3. Competitive Scenario
9.4.4.4. Regulatory Framework
9.4.4.5. India gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.4.5. Australia
9.4.5.1. Key Country Dynamics
9.4.5.2. Target Disease Prevalence
9.4.5.3. Competitive Scenario
9.4.5.4. Regulatory Framework
9.4.5.5. Australia gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.4.6. South Korea
9.4.6.1. Key Country Dynamics
9.4.6.2. Target Disease Prevalence
9.4.6.3. Competitive Scenario
9.4.6.4. Regulatory Framework
9.4.6.5. South Korea gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Key Country Dynamics
9.4.7.2. Target Disease Prevalence
9.4.7.3. Competitive Scenario
9.4.7.4. Regulatory Framework
9.4.7.5. Thailand gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.5. Latin America
9.5.1. Latin America gene synthesis (research use) market Estimates And Forecast, 2018 - 2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Target Disease Prevalence
9.5.2.3. Competitive Scenario
9.5.2.4. Regulatory Framework
9.5.2.5. Brazil gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.5.3. Mexico
9.5.3.1. Key Country Dynamics
9.5.3.2. Target Disease Prevalence
9.5.3.3. Competitive Scenario
9.5.3.4. Regulatory Framework
9.5.3.5. Mexico gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.5.4. Argentina
9.5.4.1. Key Country Dynamics
9.5.4.2. Target Disease Prevalence
9.5.4.3. Competitive Scenario
9.5.4.4. Regulatory Framework
9.5.4.5. Argentina gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.6. Middle East & Africa
9.6.1. Middle East & Africa gene synthesis (research use) market Estimates And Forecast, 2018 - 2030 (USD Million)
9.6.2. Saudi Arabia
9.6.2.1. Key Country Dynamics
9.6.2.2. Target Disease Prevalence
9.6.2.3. Competitive Scenario
9.6.2.4. Regulatory Framework
9.6.2.5. Saudi Arabia gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.6.3. South Africa
9.6.3.1. Key Country Dynamics
9.6.3.2. Target Disease Prevalence
9.6.3.3. Competitive Scenario
9.6.3.4. Regulatory Framework
9.6.3.5. South Africa gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.6.4. UAE
9.6.4.1. Key Country Dynamics
9.6.4.2. Target Disease Prevalence
9.6.4.3. Competitive Scenario
9.6.4.4. Regulatory Framework
9.6.4.5. UAE gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Target Disease Prevalence
9.6.5.3. Competitive Scenario
9.6.5.4. Regulatory Framework
9.6.5.5. Kuwait gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.2. North America
9.2.1. North America gene synthesis (research use) market estimates and forecast, 2018 - 2030 (USD Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Target Disease Prevalence
9.2.2.3. Competitive Scenario
9.2.2.4. Regulatory Framework
9.2.2.5. U.S. gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Target Disease Prevalence
9.2.3.3. Competitive Scenario
9.2.3.4. Regulatory Framework
9.2.3.5. Canada gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3. Europe
9.3.1. Europe gene synthesis (research use) market estimates and forecast, 2018 - 2030 (USD Million)
9.3.2. Germany
9.3.2.1. Key Country Dynamics
9.3.2.2. Target Disease Prevalence
9.3.2.3. Competitive Scenario
9.3.2.4. Regulatory Framework
9.3.2.5. Germany gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.3. France
9.3.3.1. Key Country Dynamics
9.3.3.2. Target Disease Prevalence
9.3.3.3. Competitive Scenario
9.3.3.4. Regulatory Framework
9.3.3.5. France gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.4. UK
9.3.4.1. Key Country Dynamics
9.3.4.2. Target Disease Prevalence
9.3.4.3. Competitive Scenario
9.3.4.4. Regulatory Framework
9.3.4.5. UK gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Target Disease Prevalence
9.3.5.3. Competitive Scenario
9.3.5.4. Regulatory Framework
9.3.5.5. Italy gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Target Disease Prevalence
9.3.6.3. Competitive Scenario
9.3.6.4. Regulatory Framework
9.3.6.5. Spain gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.7. Denmark
9.3.7.1. Key Country Dynamics
9.3.7.2. Target Disease Prevalence
9.3.7.3. Competitive Scenario
9.3.7.4. Regulatory Framework
9.3.7.5. Denmark gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.8. Sweden
9.3.8.1. Key Country Dynamics
9.3.8.2. Target Disease Prevalence
9.3.8.3. Competitive Scenario
9.3.8.4. Regulatory Framework
9.3.8.5. Sweden gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Target Disease Prevalence
9.3.9.3. Competitive Scenario
9.3.9.4. Regulatory Framework
9.3.9.5. Norway gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.10. The Netherlands
9.3.10.1. Key Country Dynamics
9.3.10.2. Target Disease Prevalence
9.3.10.3. Competitive Scenario
9.3.10.4. Regulatory Framework
9.3.10.5. The Netherlands gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.3.11. Switzerland
9.3.11.1. Key Country Dynamics
9.3.11.2. Target Disease Prevalence
9.3.11.3. Competitive Scenario
9.3.11.4. Regulatory Framework
9.3.11.5. Switzerland gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific gene synthesis (research use) market estimates and forecast, 2018 - 2030 (USD Million)
9.4.2. Japan
9.4.2.1. Key Country Dynamics
9.4.2.2. Target Disease Prevalence
9.4.2.3. Competitive Scenario
9.4.2.4. Regulatory Framework
9.4.2.5. Japan gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.4.3. China
9.4.3.1. Key Country Dynamics
9.4.3.2. Target Disease Prevalence
9.4.3.3. Competitive Scenario
9.4.3.4. Regulatory Framework
9.4.3.5. China gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Target Disease Prevalence
9.4.4.3. Competitive Scenario
9.4.4.4. Regulatory Framework
9.4.4.5. India gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.4.5. Australia
9.4.5.1. Key Country Dynamics
9.4.5.2. Target Disease Prevalence
9.4.5.3. Competitive Scenario
9.4.5.4. Regulatory Framework
9.4.5.5. Australia gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.4.6. South Korea
9.4.6.1. Key Country Dynamics
9.4.6.2. Target Disease Prevalence
9.4.6.3. Competitive Scenario
9.4.6.4. Regulatory Framework
9.4.6.5. South Korea gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Key Country Dynamics
9.4.7.2. Target Disease Prevalence
9.4.7.3. Competitive Scenario
9.4.7.4. Regulatory Framework
9.4.7.5. Thailand gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.5. Latin America
9.5.1. Latin America gene synthesis (research use) market Estimates And Forecast, 2018 - 2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Target Disease Prevalence
9.5.2.3. Competitive Scenario
9.5.2.4. Regulatory Framework
9.5.2.5. Brazil gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.5.3. Mexico
9.5.3.1. Key Country Dynamics
9.5.3.2. Target Disease Prevalence
9.5.3.3. Competitive Scenario
9.5.3.4. Regulatory Framework
9.5.3.5. Mexico gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.5.4. Argentina
9.5.4.1. Key Country Dynamics
9.5.4.2. Target Disease Prevalence
9.5.4.3. Competitive Scenario
9.5.4.4. Regulatory Framework
9.5.4.5. Argentina gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.6. Middle East & Africa
9.6.1. Middle East & Africa gene synthesis (research use) market Estimates And Forecast, 2018 - 2030 (USD Million)
9.6.2. Saudi Arabia
9.6.2.1. Key Country Dynamics
9.6.2.2. Target Disease Prevalence
9.6.2.3. Competitive Scenario
9.6.2.4. Regulatory Framework
9.6.2.5. Saudi Arabia gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.6.3. South Africa
9.6.3.1. Key Country Dynamics
9.6.3.2. Target Disease Prevalence
9.6.3.3. Competitive Scenario
9.6.3.4. Regulatory Framework
9.6.3.5. South Africa gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.6.4. UAE
9.6.4.1. Key Country Dynamics
9.6.4.2. Target Disease Prevalence
9.6.4.3. Competitive Scenario
9.6.4.4. Regulatory Framework
9.6.4.5. UAE gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Target Disease Prevalence
9.6.5.3. Competitive Scenario
9.6.5.4. Regulatory Framework
9.6.5.5. Kuwait gene synthesis market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Share Analysis, 2022
10.4. Company Profiles/Listing
10.4.1. GenScript
10.4.1.1. Overview
10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.1.3. Method Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Azenta, Inc. (GENEWIZ)
10.4.2.1. Overview
10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.2.3. Method Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Boster Biological Technology
10.4.3.1. Overview
10.4.3.2. Method Benchmarking
10.4.3.3. Strategic Initiatives
10.4.4. Twist Bioscience
10.4.4.1. Overview
10.4.4.2. Method Benchmarking
10.4.4.3. Strategic Initiatives
10.4.5. ProteoGenix, Inc
10.4.5.1. Overview
10.4.5.2. Method Benchmarking
10.4.5.3. Strategic Initiatives
10.4.6. Biomatik.
10.4.6.1. Overview
10.4.6.2. Method Benchmarking
10.4.6.3. Strategic Initiatives
10.4.7. ProMab Biotechnologies, Inc.
10.4.7.1. Overview
10.4.7.2. Method Benchmarking
10.4.7.3. Strategic Initiatives
10.4.8. Thermo Fisher Scientific, Inc
10.4.8.1. Overview
10.4.8.2. Method Benchmarking
10.4.8.3. Strategic Initiatives
10.4.9. Integrated DNA Technologies, Inc. (Danaher)
10.4.9.1. Overview
10.4.9.2. Method Benchmarking
10.4.9.3. Strategic Initiatives
10.4.10. OriGene Technologies, Inc.
10.4.10.1. Overview
10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.10.3. Method Benchmarking
10.4.10.4. Strategic Initiatives
10.2. Strategy Mapping
10.3. Company Share Analysis, 2022
10.4. Company Profiles/Listing
10.4.1. GenScript
10.4.1.1. Overview
10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.1.3. Method Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Azenta, Inc. (GENEWIZ)
10.4.2.1. Overview
10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.2.3. Method Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Boster Biological Technology
10.4.3.1. Overview
10.4.3.2. Method Benchmarking
10.4.3.3. Strategic Initiatives
10.4.4. Twist Bioscience
10.4.4.1. Overview
10.4.4.2. Method Benchmarking
10.4.4.3. Strategic Initiatives
10.4.5. ProteoGenix, Inc
10.4.5.1. Overview
10.4.5.2. Method Benchmarking
10.4.5.3. Strategic Initiatives
10.4.6. Biomatik.
10.4.6.1. Overview
10.4.6.2. Method Benchmarking
10.4.6.3. Strategic Initiatives
10.4.7. ProMab Biotechnologies, Inc.
10.4.7.1. Overview
10.4.7.2. Method Benchmarking
10.4.7.3. Strategic Initiatives
10.4.8. Thermo Fisher Scientific, Inc
10.4.8.1. Overview
10.4.8.2. Method Benchmarking
10.4.8.3. Strategic Initiatives
10.4.9. Integrated DNA Technologies, Inc. (Danaher)
10.4.9.1. Overview
10.4.9.2. Method Benchmarking
10.4.9.3. Strategic Initiatives
10.4.10. OriGene Technologies, Inc.
10.4.10.1. Overview
10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.10.3. Method Benchmarking
10.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 4 Global gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 5 Global gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 6 Global gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 7 Global gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 8 North America gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 9 North America gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 10 North America gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 11 North America gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 12 North America synthesis market by Application, 2018 - 2030 (USD Million)
Table 13 U.S. gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 14 U.S. gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 15 U.S. gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 16 U.S. gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 17 U.S. gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 18 Canada gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 19 Canada gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 20 Canada gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 21 Canada gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 22 Canada gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 23 Europe gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 24 Europe gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 25 Europe gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 26 Europe gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 27 Europe gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 28 UK gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 29 UK gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 30 UK gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 31 UK gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 32 UK gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 33 Germany gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 34 Germany gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 35 Germany gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 36 Germany gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 37 Germany gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 38 France gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 39 France gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 40 France gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 41 France gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 42 France gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 43 Italy gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 44 Italy gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 45 Italy gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 46 Italy gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 47 Italy gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 48 Spain gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 49 Spain gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 50 Spain gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 51 Spain gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 52 Spain gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 53 Denmark gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 54 Denmark gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 55 Denmark gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 56 Denmark gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 57 Denmark gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 58 Sweden gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 59 Sweden gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 60 Sweden gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 61 Sweden gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 62 Sweden gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 63 Norway gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 64 Norway gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 65 Norway gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 66 Norway gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 67 Norway gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 68 The Netherlands gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 69 The Netherlands gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 70 The Netherlands gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 71 The Netherlands gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 72 The Netherlands gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 73 Switzerland gene synthesis (research use) market by End- Use, 2018 - 2030 (USD Million)
Table 74 Switzerland gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 75 Switzerland gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 76 Switzerland gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 77 Switzerland gene synthesis (research use) market by Research Use, 2018 - 2030 (USD Million)
Table 78 Asia Pacific gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 79 Asia Pacific gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 80 Asia Pacific gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 81 Asia Pacific gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 82 Asia Pacific gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 83 Japan gene synthesis (research use) market by End- Use, 2018 - 2030 (USD Million)
Table 84 Japan gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 85 Japan gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 86 Japan gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 87 Japan gene synthesis (research use) market by Research Use, 2018 - 2030 (USD Million)
Table 88 China gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 89 China gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 90 China gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 91 China gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 92 China gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 93 India gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 94 India gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 95 India gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 96 India gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 97 India gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 98 Australia gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 99 Australia gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 100 Australia gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 101 Australia gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 102 Australia gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 103 Thailand gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 104 Thailand gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 105 Thailand gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 106 Thailand gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 107 Thailand gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 108 South Korea gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 109 South Korea gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 110 South Korea gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 111 South Korea gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 112 South Korea synthesis market by Research Phase, 2018 - 2030 (USD Million)
Table 113 Latin America gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 114 Latin America gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 115 Latin America gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 116 Latin America gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 117 Latin America gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 118 Brazil gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 119 Brazil gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 120 Brazil gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 121 Brazil gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 122 Brazil gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 123 Mexico gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 124 Mexico gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 125 Mexico gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 126 Mexico gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 127 Mexico gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 128 Argentina gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 129 Argentina gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 130 Argentina gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 131 Argentina gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 132 Argentina gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 133 Middle East & Africa gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 134 Middle East & Africa gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 135 Middle East & Africa gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 136 Middle East & Africa gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 137 Middle East & Africa gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 143 South Africa gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 144 South Africa gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 145 South Africa gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 146 South Africa gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 147 South Africa gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 148 UAE gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 149 UAE gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 150 UAE gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 151 UAE gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 152 UAE gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 153 Kuwait gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 154 Kuwait gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 155 Kuwait gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 156 Kuwait gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 157 Kuwait gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 158 Participant’s overview
Table 159 Financial performance
Table 160 Key companies undergoing expansions
Table 161 Key companies undergoing acquisitions
Table 162 Key companies undergoing collaborations
Table 163 Key companies launching new products/services
Table 164 Key companies undergoing partnerships
Table 165 Key companies undertaking other strategies
Table 2 List of abbreviations
Table 3 Global gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 4 Global gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 5 Global gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 6 Global gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 7 Global gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 8 North America gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 9 North America gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 10 North America gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 11 North America gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 12 North America synthesis market by Application, 2018 - 2030 (USD Million)
Table 13 U.S. gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 14 U.S. gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 15 U.S. gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 16 U.S. gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 17 U.S. gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 18 Canada gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 19 Canada gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 20 Canada gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 21 Canada gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 22 Canada gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 23 Europe gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 24 Europe gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 25 Europe gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 26 Europe gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 27 Europe gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 28 UK gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 29 UK gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 30 UK gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 31 UK gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 32 UK gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 33 Germany gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 34 Germany gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 35 Germany gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 36 Germany gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 37 Germany gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 38 France gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 39 France gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 40 France gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 41 France gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 42 France gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 43 Italy gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 44 Italy gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 45 Italy gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 46 Italy gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 47 Italy gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 48 Spain gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 49 Spain gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 50 Spain gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 51 Spain gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 52 Spain gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 53 Denmark gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 54 Denmark gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 55 Denmark gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 56 Denmark gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 57 Denmark gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 58 Sweden gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 59 Sweden gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 60 Sweden gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 61 Sweden gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 62 Sweden gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 63 Norway gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 64 Norway gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 65 Norway gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 66 Norway gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 67 Norway gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 68 The Netherlands gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 69 The Netherlands gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 70 The Netherlands gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 71 The Netherlands gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 72 The Netherlands gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 73 Switzerland gene synthesis (research use) market by End- Use, 2018 - 2030 (USD Million)
Table 74 Switzerland gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 75 Switzerland gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 76 Switzerland gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 77 Switzerland gene synthesis (research use) market by Research Use, 2018 - 2030 (USD Million)
Table 78 Asia Pacific gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 79 Asia Pacific gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 80 Asia Pacific gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 81 Asia Pacific gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 82 Asia Pacific gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 83 Japan gene synthesis (research use) market by End- Use, 2018 - 2030 (USD Million)
Table 84 Japan gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 85 Japan gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 86 Japan gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 87 Japan gene synthesis (research use) market by Research Use, 2018 - 2030 (USD Million)
Table 88 China gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 89 China gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 90 China gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 91 China gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 92 China gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 93 India gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 94 India gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 95 India gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 96 India gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 97 India gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 98 Australia gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 99 Australia gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 100 Australia gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 101 Australia gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 102 Australia gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 103 Thailand gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 104 Thailand gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 105 Thailand gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 106 Thailand gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 107 Thailand gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 108 South Korea gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 109 South Korea gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 110 South Korea gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 111 South Korea gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 112 South Korea synthesis market by Research Phase, 2018 - 2030 (USD Million)
Table 113 Latin America gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 114 Latin America gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 115 Latin America gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 116 Latin America gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 117 Latin America gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 118 Brazil gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 119 Brazil gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 120 Brazil gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 121 Brazil gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 122 Brazil gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 123 Mexico gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 124 Mexico gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 125 Mexico gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 126 Mexico gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 127 Mexico gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 128 Argentina gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 129 Argentina gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 130 Argentina gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 131 Argentina gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 132 Argentina gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 133 Middle East & Africa gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 134 Middle East & Africa gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 135 Middle East & Africa gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 136 Middle East & Africa gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 137 Middle East & Africa gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 143 South Africa gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 144 South Africa gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 145 South Africa gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 146 South Africa gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 147 South Africa gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 148 UAE gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 149 UAE gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 150 UAE gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 151 UAE gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 152 UAE gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 153 Kuwait gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 154 Kuwait gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 155 Kuwait gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 156 Kuwait gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 157 Kuwait gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 158 Participant’s overview
Table 159 Financial performance
Table 160 Key companies undergoing expansions
Table 161 Key companies undergoing acquisitions
Table 162 Key companies undergoing collaborations
Table 163 Key companies launching new products/services
Table 164 Key companies undergoing partnerships
Table 165 Key companies undertaking other strategies
List of Figures
Fig. 1 Global gene synthesis (research use) market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market snapshot
Fig. 13 Segment snapshot
Fig. 14 Segment snapshot
Fig. 15 Segment snapshot
Fig. 16 Competitive landscape snapshot
Fig. 17 Market trends & outlook
Fig. 18 Porter’s five force analysis
Fig. 19 SWOT analysis, by factor (Political, Economic, Social, Technological, and Legal)
Fig. 20 Global gene synthesis (research use) market: method outlook key takeaways
Fig. 21 Global gene synthesis (research use) market: method movement analysis
Fig. 22 Solid-phase synthesis market, 2018 - 2030 (USD Million)
Fig. 23 Chip-based synthesis market, 2018 - 2030 (USD Million)
Fig. 24 PCR-based enzyme synthesis market, 2018 - 2030 (USD Million)
Fig. 25 Global gene synthesis (research use) market: services outlook and key takeaways
Fig. 26 Global gene synthesis (research use) market: services movement analysis
Fig. 27 Antibody DNA synthesis market, 2018 - 2030 (USD Million)
Fig. 28 Viral DNA synthesis market, 2018 - 2030 (USD Million)
Fig. 29 Others market, 2018 - 2030 (USD Million)
Fig. 30 Global gene synthesis (research use) market: application outlook and key takeaways
Fig. 31 Global gene synthesis (research use) market: application movement analysis
Fig. 32 Gene & cell therapy development market, 2018 - 2030 (USD Million)
Fig. 33 Vaccine development market, 2018 - 2030 (USD Million)
Fig. 34 Others market, 2018 - 2030 (USD Million)
Fig. 35 Global gene synthesis (research use) market: End-use outlook key takeaways
Fig. 36 Global gene synthesis (research use) market: end-use movement analysis
Fig. 37 Biotechnology and pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 38 Academic and government research institutes market, 2018 - 2030 (USD Million)
Fig. 39 Contract research organizations market, 2018 - 2030 (USD Million)
Fig. 40 Global gene synthesis (research use) market: research phase outlook and key takeaways
Fig. 41 Global gene synthesis (research use) market: research phase movement analysis
Fig. 42 Preclinical market, 2018 - 2030 (USD Million)
Fig. 43 Clinical market, 2018 - 2030 (USD Million)
Fig. 44 Regional marketplace: Key takeaways
Fig. 45 Regional marketplace: Key takeaways
Fig. 46 North America gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 US gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Target disease prevalence, 2022
Fig. 49 Key country dynamics
Fig. 50 Canada gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Target disease prevalence, 2022
Fig. 52 Key country dynamics
Fig. 53 Europe gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 UK gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Target disease prevalence, 2022
Fig. 56 Key country dynamics
Fig. 57 Germany gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Target disease prevalence, 2018-2030
Fig. 59 Key country dynamics
Fig. 60 France gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Target disease prevalence 2018-2030
Fig. 62 Key country dynamics
Fig. 63 Spain gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Target disease prevalence 2022
Fig. 65 Key country dynamics
Fig. 66 Italy gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Target disease prevalence 2022
Fig. 68 Key country dynamics
Fig. 69 Denmark gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Target disease prevalence
Fig. 71 Key country dynamics
Fig. 72 Sweden gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Target disease prevalence in Sweden
Fig. 74 Key country dynamics
Fig. 75 Norway gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Target disease prevalence in Norway 2022
Fig. 77 Key country dynamics
Fig. 78 Switzerland gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Target disease prevalence in Switzerland 2022
Fig. 80 Key country dynamics
Fig. 81 The Netherlands gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Target disease prevalence in The Netherlands 2022
Fig. 83 Key country dynamics
Fig. 84 Asia pacific gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Japan gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Target disease prevalence, 2022
Fig. 87 Key country dynamics
Fig. 88 China gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Target disease prevalence, 2018-2030
Fig. 90 Key country dynamics
Fig. 91 India gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Target disease prevalence 2018-2030
Fig. 93 Key country dynamics
Fig. 94 Australia gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Target disease prevalence 2022
Fig. 96 Key country dynamics
Fig. 97 Thailand gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Target disease prevalence 2022
Fig. 99 Key country dynamics
Fig. 100 South Korea gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Target disease prevalence
Fig. 102 Key country dynamics
Fig. 103 Latin America gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 Brazil gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Target disease prevalence in Norway 2022
Fig. 106 Key country dynamics
Fig. 107 Mexico gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 108 Target disease prevalence in Norway 2022
Fig. 109 Key country dynamics
Fig. 110 Argentina gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 111 Target disease prevalence in Norway 2022
Fig. 112 Key country dynamics
Fig. 113 Middle East & Africa gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 114 Target disease prevalence in Norway 2022
Fig. 115 Key country dynamics
Fig. 116 South Africa gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 117 Target disease prevalence in Norway 2022
Fig. 118 Key country dynamics
Fig. 119 Saudi Arabia gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 120 Target disease prevalence in Norway 2022
Fig. 121 Key country dynamics
Fig. 122 UAE gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 123 Target disease prevalence in Norway 2022
Fig. 124 Key country dynamics
Fig. 125 Kuwait gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 126 Target disease prevalence in Norway 2022
Fig. 127 Key country dynamics
Fig. 128 Market participant categorization
Fig. 129 Company market share analysis, 2022
Fig. 130 Strategic framework
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market snapshot
Fig. 13 Segment snapshot
Fig. 14 Segment snapshot
Fig. 15 Segment snapshot
Fig. 16 Competitive landscape snapshot
Fig. 17 Market trends & outlook
Fig. 18 Porter’s five force analysis
Fig. 19 SWOT analysis, by factor (Political, Economic, Social, Technological, and Legal)
Fig. 20 Global gene synthesis (research use) market: method outlook key takeaways
Fig. 21 Global gene synthesis (research use) market: method movement analysis
Fig. 22 Solid-phase synthesis market, 2018 - 2030 (USD Million)
Fig. 23 Chip-based synthesis market, 2018 - 2030 (USD Million)
Fig. 24 PCR-based enzyme synthesis market, 2018 - 2030 (USD Million)
Fig. 25 Global gene synthesis (research use) market: services outlook and key takeaways
Fig. 26 Global gene synthesis (research use) market: services movement analysis
Fig. 27 Antibody DNA synthesis market, 2018 - 2030 (USD Million)
Fig. 28 Viral DNA synthesis market, 2018 - 2030 (USD Million)
Fig. 29 Others market, 2018 - 2030 (USD Million)
Fig. 30 Global gene synthesis (research use) market: application outlook and key takeaways
Fig. 31 Global gene synthesis (research use) market: application movement analysis
Fig. 32 Gene & cell therapy development market, 2018 - 2030 (USD Million)
Fig. 33 Vaccine development market, 2018 - 2030 (USD Million)
Fig. 34 Others market, 2018 - 2030 (USD Million)
Fig. 35 Global gene synthesis (research use) market: End-use outlook key takeaways
Fig. 36 Global gene synthesis (research use) market: end-use movement analysis
Fig. 37 Biotechnology and pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 38 Academic and government research institutes market, 2018 - 2030 (USD Million)
Fig. 39 Contract research organizations market, 2018 - 2030 (USD Million)
Fig. 40 Global gene synthesis (research use) market: research phase outlook and key takeaways
Fig. 41 Global gene synthesis (research use) market: research phase movement analysis
Fig. 42 Preclinical market, 2018 - 2030 (USD Million)
Fig. 43 Clinical market, 2018 - 2030 (USD Million)
Fig. 44 Regional marketplace: Key takeaways
Fig. 45 Regional marketplace: Key takeaways
Fig. 46 North America gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 US gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Target disease prevalence, 2022
Fig. 49 Key country dynamics
Fig. 50 Canada gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Target disease prevalence, 2022
Fig. 52 Key country dynamics
Fig. 53 Europe gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 UK gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Target disease prevalence, 2022
Fig. 56 Key country dynamics
Fig. 57 Germany gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Target disease prevalence, 2018-2030
Fig. 59 Key country dynamics
Fig. 60 France gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Target disease prevalence 2018-2030
Fig. 62 Key country dynamics
Fig. 63 Spain gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Target disease prevalence 2022
Fig. 65 Key country dynamics
Fig. 66 Italy gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Target disease prevalence 2022
Fig. 68 Key country dynamics
Fig. 69 Denmark gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Target disease prevalence
Fig. 71 Key country dynamics
Fig. 72 Sweden gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Target disease prevalence in Sweden
Fig. 74 Key country dynamics
Fig. 75 Norway gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Target disease prevalence in Norway 2022
Fig. 77 Key country dynamics
Fig. 78 Switzerland gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Target disease prevalence in Switzerland 2022
Fig. 80 Key country dynamics
Fig. 81 The Netherlands gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Target disease prevalence in The Netherlands 2022
Fig. 83 Key country dynamics
Fig. 84 Asia pacific gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Japan gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Target disease prevalence, 2022
Fig. 87 Key country dynamics
Fig. 88 China gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Target disease prevalence, 2018-2030
Fig. 90 Key country dynamics
Fig. 91 India gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Target disease prevalence 2018-2030
Fig. 93 Key country dynamics
Fig. 94 Australia gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Target disease prevalence 2022
Fig. 96 Key country dynamics
Fig. 97 Thailand gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Target disease prevalence 2022
Fig. 99 Key country dynamics
Fig. 100 South Korea gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Target disease prevalence
Fig. 102 Key country dynamics
Fig. 103 Latin America gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 Brazil gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Target disease prevalence in Norway 2022
Fig. 106 Key country dynamics
Fig. 107 Mexico gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 108 Target disease prevalence in Norway 2022
Fig. 109 Key country dynamics
Fig. 110 Argentina gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 111 Target disease prevalence in Norway 2022
Fig. 112 Key country dynamics
Fig. 113 Middle East & Africa gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 114 Target disease prevalence in Norway 2022
Fig. 115 Key country dynamics
Fig. 116 South Africa gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 117 Target disease prevalence in Norway 2022
Fig. 118 Key country dynamics
Fig. 119 Saudi Arabia gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 120 Target disease prevalence in Norway 2022
Fig. 121 Key country dynamics
Fig. 122 UAE gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 123 Target disease prevalence in Norway 2022
Fig. 124 Key country dynamics
Fig. 125 Kuwait gene synthesis (research use) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 126 Target disease prevalence in Norway 2022
Fig. 127 Key country dynamics
Fig. 128 Market participant categorization
Fig. 129 Company market share analysis, 2022
Fig. 130 Strategic framework
Companies Mentioned
- GenScript
- Azenta, Inc. (GENEWIZ)
- Boster Biological Technology
- Twist Bioscience
- ProteoGenix, Inc
- Biomatik.
- ProMab Biotechnologies, Inc.
- Thermo Fisher Scientific, Inc
- Integrated DNA Technologies, Inc. (Danaher)
- OriGene Technologies, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | September 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 1.57 Billion |
| Forecasted Market Value ( USD | $ 5.14 Billion |
| Compound Annual Growth Rate | 16.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
